Orotic acid (Standard) is the analytical standard of Orotic acid. This product is intended for research and analytical applications. Orotic acid (6-Carboxyuracil), a precursor in biosynthesis of pyrimidine nucleotides and RNA, is released from the mitochondrial dihydroorotate dehydrogenase (DHODH) for conversion to UMP by the cytoplasmic UMP synthase enzyme. Orotic acid is a marker for […]

Orotic acid (Standard) is the analytical standard of Orotic acid. This product is intended for research and analytical applications. Orotic acid (6-Carboxyuracil), a precursor in biosynthesis of pyrimidine nucleotides and RNA, is released from the mitochondrial dihydroorotate dehydrogenase (DHODH) for conversion to UMP by the cytoplasmic UMP synthase enzyme. Orotic acid is a marker for […]

Orphenadrine ((±)-Orphenadrine) is a skeletal muscle relaxant and NMDA antagonist that also has antiparkinsonian, antihistamine, antitremor, antispasmodic, and analgesic effects. Orphenadrine inhibits the binding of [3H]MK-801 to the phencyclidine (PCP) binding site of the NMDA receptor. Orphenadrine is also an anticholinergic and cytochrome P450 (CYP) 2B inducer. Orphenadrine may exert pro-tumor effects, causing CAR nuclear […]

OS9 Human Pre-designed siRNA Set A contains three designed siRNAs for OS9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSBP Human Pre-designed siRNA Set A contains three designed siRNAs for OSBP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSBP2 Human Pre-designed siRNA Set A contains three designed siRNAs for OSBP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSBPL10 Human Pre-designed siRNA Set A contains three designed siRNAs for OSBPL10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSBPL11 Human Pre-designed siRNA Set A contains three designed siRNAs for OSBPL11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSBPL1A Human Pre-designed siRNA Set A contains three designed siRNAs for OSBPL1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSBPL2 Human Pre-designed siRNA Set A contains three designed siRNAs for OSBPL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSBPL3 Human Pre-designed siRNA Set A contains three designed siRNAs for OSBPL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSBPL5 Human Pre-designed siRNA Set A contains three designed siRNAs for OSBPL5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSBPL6 Human Pre-designed siRNA Set A contains three designed siRNAs for OSBPL6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSBPL7 Human Pre-designed siRNA Set A contains three designed siRNAs for OSBPL7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSBPL8 Human Pre-designed siRNA Set A contains three designed siRNAs for OSBPL8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSBPL9 Human Pre-designed siRNA Set A contains three designed siRNAs for OSBPL9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSCAR Human Pre-designed siRNA Set A contains three designed siRNAs for OSCAR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Oseltamivir acid-13C,d3 (GS 4071-13C,d3; Ro 64-0802-13C,d3) is a 13C- and deuterium-labeled Oseltamivir acid (HY-13318). Oseltamivir acid is the active metabolite of Oseltamivir phosphate and inhibits influenza virus neuraminidase (IC50=2 nM). Oseltamivir acid is orally active and can be used to study influenza A/B infections[1][2][3][4][5].

Oseltamivir (phosphate) (Standard) is the analytical standard of Oseltamivir (phosphate). This product is intended for research and analytical applications. Oseltamivir phosphate (GS 4104) is a neuraminidase inhibitor recommended for the treatment and prophylaxis of influenza A and B.

OSGEP Human Pre-designed siRNA Set A contains three designed siRNAs for OSGEP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSGIN1 Human Pre-designed siRNA Set A contains three designed siRNAs for OSGIN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSM Human Pre-designed siRNA Set A contains three designed siRNAs for OSM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSM-S-106 is a pro-inhibitor and that inhibition of PfAsnRS occurs via enzyme-mediated production of an Asn-OSM-S-106 adduct. OSM-S-106 inhibits protein translation and activates the amino acid starvation response. OSM-S-106 exhibits selective activity against Plasmodium blood and liver stages and low intrinsic clearance by human microsomes[1].

OSMR Human Pre-designed siRNA Set A contains three designed siRNAs for OSMR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSR1 Human Pre-designed siRNA Set A contains three designed siRNAs for OSR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSR2 Human Pre-designed siRNA Set A contains three designed siRNAs for OSR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OST4 Human Pre-designed siRNA Set A contains three designed siRNAs for OST4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSTC Human Pre-designed siRNA Set A contains three designed siRNAs for OSTC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSTF1 Human Pre-designed siRNA Set A contains three designed siRNAs for OSTF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSTM1 Human Pre-designed siRNA Set A contains three designed siRNAs for OSTM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSTN Human Pre-designed siRNA Set A contains three designed siRNAs for OSTN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OSU-ERb-12 is a ERβ agonist, and suppress ovarian cancer cell proliferation in vitro and in vivo. OSU-ERb-12 decreases the expression of Snail[1][2].

OTC Human Pre-designed siRNA Set A contains three designed siRNAs for OTC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OTNE-13C3 is 13C labeled 2-methoxy-4-propylphenol.

OTOA Human Pre-designed siRNA Set A contains three designed siRNAs for OTOA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OTOF Human Pre-designed siRNA Set A contains three designed siRNAs for OTOF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OTOG Human Pre-designed siRNA Set A contains three designed siRNAs for OTOG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OTOGL Human Pre-designed siRNA Set A contains three designed siRNAs for OTOGL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OTOP1 Human Pre-designed siRNA Set A contains three designed siRNAs for OTOP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OTOP2 Human Pre-designed siRNA Set A contains three designed siRNAs for OTOP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OTOR Human Pre-designed siRNA Set A contains three designed siRNAs for OTOR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OTOS Human Pre-designed siRNA Set A contains three designed siRNAs for OTOS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OTP Human Pre-designed siRNA Set A contains three designed siRNAs for OTP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OTUB1 Human Pre-designed siRNA Set A contains three designed siRNAs for OTUB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OTUB2 Human Pre-designed siRNA Set A contains three designed siRNAs for OTUB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

OTUB2-IN-1, a specific inhibitor of OTUB2 (KD: ~12 μM), reduces PD-L1 protein expression in tumor cells and inhibits tumor growth by promoting robust intra-tumor infiltration of cytotoxic T lymphocytes (CTL) [1].